I personally think LPC is not day trader, and LPC buys the shares and hold to the Z160 result to make big profit. Corrigan did not invite LPC to flip the PPS!
Sentiment: Strong Buy
LPC sold it's all shares? LPC is an insider, does this means LPC has no confidence about Z160 P2 result?
I think it was the recent run up make Corrigan decide1:6 R/S, not he is more confidence about the result.
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.
This is different calium channel blocker targeting Nav1.9, T-type! only found in neurons!
Shareholder meeting votes for "NO" for dilution.
Zalicus has LPC to get the money.
If results are positive, partnership or buyout, Zalicus does not need more fund now!
It is only two weeks left to see the positive results. Z160 is going to show its efficacy in pain control.
Looking at AH trading, the PPS may go down first, then back into 9-10 dollars with institutions buying in.